The American Thoracic Society is pleased to announce the launch of the open access journal, ATS Scholar. ATS Scholar is an exciting online, peer-reviewed journal focusing on content related to education and training of health professionals relevant to adult and pediatric pulmonary, critical care and sleep medicine.
The ATS Foundation Research Program and the American Lung Association have awarded Donald Sullivan, MD, of Oregon Health & Science University a $100,000 Foundation Partner grant. The ATS Foundation Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).
Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (miniscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and may lead to chronic obstructive pulmonary disease (COPD), according to new research published online in the Annals of the American Thoracic Society.
The ATS Foundation Research Program/Pulmonary Hypertension Association has awarded Rahul Kumar, PhD, of the University of California, San Francisco, a $80,000 Foundation Partner grant. A $50,000 Foundation Partner grant was awarded to Jason Boehme, MD, also of the University of California, San Francisco. Ke Yuan, PhD, of Boston Children’s Hospital is the 2019 recipient of the Aldrighetti Research Award for Young Investigators. The award, in the amount of $80,000, is sponsored by Actelion Pharmaceuticals US, Inc, through a partnership with the Pulmonary Hypertension Association.
The ATS Foundation Research Program has announced that 17 researchers have been awarded one-year $40,000 Unrestricted Research Grants to advance pulmonary, critical care and sleep medicine.
ResMed (NYSE: RMD, ASX: RMD) and ATS Foundation have awarded their third $100,000 Research Fellowship grant to Claude Farah, PhD, of the Woolcock Institute of Medical Research in Sydney, Australia, to study how remote monitoring can help improve the management of patients with chronic obstructive pulmonary disease, or COPD.
Changes in the lung microbiome may help predict how well critically ill patients will respond to care, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
While deaths steadily declined over a decade in intensive care units at hospitals with few minority patients, in ICUs with large numbers of minority patients, there was less improvement, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Philadelphia, the City of Brotherly Love, will play host to the ATS 2020 International Conference, the biggest gathering of scientists and clinicians in pulmonary, critical care, and sleep medicine.
Weight loss in obese patients with obstructive sleep apnea (OSA) appears to improve sleep apnea primarily by reducing tongue fat, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The ATS Foundation Research Program/Foundation for Sarcoidosis has awarded Nicholas Arger, MD, of the University of California, San Francisco a $80,000 Foundation Partner grant. The ATS Foundation Partner Grant provides crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
A small wildfire in San Diego County in 2017 resulted in a big uptick in children visiting the emergency room for breathing problems, according to new research published online in the Annals of the American Thoracic Society.
While the American Thoracic Society appreciates that the FDA took action on certain flavored cartridge-based vaping products, it is disappointed that the Administration chose to not follow through on its September 2019 promise to clear the market of all flavored electronic nicotine delivery projects.
The number of people newly infected each year and the number of people living with nontuberculous mycobacterial lung disease appears to be increasing, especially among women and those 65 and older, according to new research published online in the Annals of the American Thoracic Society.
Dec. 6, 2019 – Reductions in air pollution yielded fast and dramatic impacts on health-outcomes, as well as decreases in all-cause morbidity, according to findings in “Health Benefits of Air Pollution Reduction,” new research published in the American Thoracic Society’s journal, Annals of the American Thoracic Society.
The World Health Organization has set a goal of ending the AIDS epidemic by 2030.
The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society and the Infectious Diseases Society of America have published an official clinical guideline on the treatment of drug-resistant tuberculosis (DR-TB) in the Nov. 15 American Journal of Respiratory and Critical Care Medicine.
ATS Offers Educational Resources for Establishing a Plan to Deal with an Attack and Information to Achieve Daily Control of Symptoms
In support of World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a member, calls for an end to preventable pneumonia deaths, ensuring equitable access to interventions for prevention and control of pneumonia.
Only about 6 in 10 lung cancer patients in the United States receive the minimal lung cancer treatments recommended by the National Comprehensive Cancer Network guidelines, according to new research published online in the Annals of the American Thoracic Society.
Following today’s release of the World Health Organization’s Global Tuberculosis Report 2019, the American Thoracic Society joins the WHO in calling for redoubled efforts to end the global TB pandemic by 2030, the goal set by the global community in the United Nations Political Declaration to End Tuberculosis on Sept. 26, 2018.
Today, the CDC is expected to release new recommendations for evaluation and treatment of patients with suspected vaping-associated lung injury (VALI). The document -- “Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette Use, or Vaping, Associated Lung Injury — United States, October 2019” -- was written in concert with national experts identified from professional medical societies, including the ATS.
In adolescent and adult patients with cystic fibrosis taking lumacaftor-ivacaftor (ORKAMBI®), the combination drug appears to improve lung function and body weight and reduce the need for intravenous antibiotic treatment, according to a French study published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Many admissions to the intensive care unit may be preventable, potentially decreasing health care costs and improving care, according to new research published online in the Annals of the American Thoracic Society.
The American Thoracic Society and the Infectious Diseases Society of America have published an official clinical guideline on the diagnosis and treatment of adults with community acquired pneumonia (CAP) in the ATS’s Oct. 1 American Journal of Respiratory and Critical Care Medicine.
Women with asthma appear more likely to have lower levels of “free” (not attached to proteins) testosterone than women who do not have asthma, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Today, on World Lung Day (WLD), the American Thoracic Society is united with members of the Forum of International Respiratory Societies (FIRS) and WLD partner organizations to advocate for respiratory health globally and call on policymakers to ensure that everyone has access to the services they need to improve their lung health.
In patients with high blood pressure resistant to treatment who also have obstructive sleep apnea (OSA), the more severe their OSA, the higher their blood pressure, according to new research published online in the Annals of the American Thoracic Society.
The ATS congratulates the FDA important, but belated action, to remove flavored e-cigarette products from the U.S. market. Since e-cigarette products first emerged in the U.S., the American Thoracic Society has consistently called on FDA to aggressively regulate e-cigarettes and has repeatedly urged the FDA to ban flavored e-cigarette from the U.S. market.
The American Thoracic Society applauds Michigan Governor Gretchen Whitmer’s decision to ban the sale of all flavored e-cigarette and vaping products in the state of Michigan.
The American Thoracic Society has published an official clinical guideline on laboratory diagnosis of fungal infections in pulmonary and critical care medicine in the Society’s Aug. 30 American Journal of Respiratory and Critical Care Medicine.
Today the FDA issued its proposal for graphic warnings on cigarettes, a long overdue step says the American Thoracic Society in curbing the adverse health effects associated with smoking. Comments on the proposed rule are due by October 15, 2019. The FDA is required to issue a final rule by March 15, 2020.
Certain traits may define a type of obstructive sleep apnea that can be effectively treated with an oral appliance, according to new research published online in the Annals of the American Thoracic Society.
The American Thoracic Society has published an official clinical guideline on the evaluation and management of obesity hypoventilation syndrome in the Society’s Aug. 1 American Journal of Respiratory and Critical Care Medicine.
Patients with cystic fibrosis who take ivacaftor appear to have fewer respiratory infections over time than those not taking the drug, according to new research published online in the Annals of the American Thoracic Society.
Last Friday afternoon, July 12, 2019, a federal court decision established deadlines for e-cigarette manufacturers and makers of candy-flavored cigars to submit their products for FDA review. The Court took this action after medical and public health groups sued the Food and Drug Administration for the agency’s failure to appropriately regulate e-cigarettes and cigars in a timely and effective manner.
David Geoffrey Chapman, BSc, PhD, of University of Technology in Sydney, Australia, has been awarded the new ATS Foundation/ResMed Research Fellowship in Sleep-disordered Breathing and PAP Therapy.
E-cigarette vaping with nicotine appears to hamper mucus clearance from the airways, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
The American Thoracic Society is concerned by today’s announcement of the Trump Administration’s restrictions on federal support for fetal tissue research.
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS’s American Journal of Respiratory and Critical Care Medicine.
Patients with chronic obstructive pulmonary disease, or COPD, who are covered by a high-deductible insurance plan are more likely to forgo needed health care because of cost than COPD patients covered by lower-deductible plans
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right